Related Experiment Video
Updated: Aug 9, 2025
05:05
A Modified Precipitation Method to Isolate Urinary Exosomes
Published on: January 16, 2015
17.7K
Extracellular Vesicles in Kidney Diseases: Moving Forward.
Uta Erdbrügger1, Ewout J Hoorn2, Thu H Le3
1Division of Nephrology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia.
Kidney360
|February 23, 2023
Summary
Extracellular vesicles (EVs) are promising biomarkers and therapeutic agents for kidney diseases. Research highlights their potential in diagnostics and treatment, though challenges in characterization and validation remain.
Area of Science:
- Nephrology
- Biomedical Sciences
- Cell Biology
Background:
- Extracellular vesicles (EVs) are cell-derived mediators with potential in kidney disease.
- EVs carry cargo reflecting parent cell status, making them sensitive biomarkers.
- They mediate communication within the kidney and between organs in kidney disease.
Purpose of the Study:
- To explore the evolving role of EVs in kidney health and disease.
- To discuss the potential of urinary EVs (uEVs) as biomarkers and therapeutic agents.
- To identify current challenges and future directions in EV research for nephrology.
Main Methods:
- Review of current literature on EVs in kidney diseases.
- Analysis of EV cargo for disease-specific information.
- Exploration of EV separation and characterization techniques.
- Assessment of therapeutic applications, particularly in acute kidney injury (AKI) models.
Main Results:
- EVs show promise as sensitive and disease-specific biomarkers for various kidney conditions.
- Urinary EVs (uEVs) offer a non-invasive window into kidney pathophysiology.
- Challenges include EV heterogeneity, separation, characterization, and need for larger cohort validation.
- Therapeutic potential of EVs, especially uEVs, is being investigated in preclinical models.
Conclusions:
- EVs represent a rapidly advancing field with significant potential for kidney disease diagnostics and therapeutics.
- Further research is needed for biomarker validation, simpler diagnostic tools, and translation to clinical practice.
- The development of sensitive EV measurement tools is crucial for clinical application.
Related Concept Videos
01:10Nephrons
3.2K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.2K
01:20Renal Corpuscle
3.0K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
3.0K
01:36Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
01:24Nephrotic Syndrome I : Introduction
15
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
15
01:15Drug Elimination by Renal Route: Tubular Secretion
2.5K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.5K
01:28Renal Drug Excretion: Tubular Secretion
244
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
244